This study reported significantly lower plasma levels of whole CCN2 in multiple myeloma (MM) patients compared with healthy controls, and in MM patients with bone disease compared with those without (Munemasa et al. 2007). The gene discussed is CCN2; the disease is Miyoshi myopathy.